Collect Records says it is impossible to continue having Martin Shkreli as investor over raising Daraprim price from $13.50 per tablet to $750A rock music label has severed ties with the US hedge fund manager who became a global pariah for raising the price of a life-saving drug by 5000%.
Collect Records said it was “upset on every level” to memorize that Martin Shkreli,the boss of pharmaceutical company Turing who is a fan of punk and emo music and a supportive investor in the label, had acquired overnight notoriety for increasing the cost of Daraprim from $13.50 per tablet to $750 (£490).
Continue reading...
Source: theguardian.com